BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32922477)

  • 1. NF-κB-dependent Mechanism of Action of c-Myc Inhibitor 10058-F4: Highlighting a Promising Effect of c-Myc Inhibition in Leukemia Cells, Irrespective of p53 Status.
    Sayyadi M; Safaroghli-Azar A; Safa M; Abolghasemi H; Momeny M; Bashash D
    Iran J Pharm Res; 2020; 19(1):153-165. PubMed ID: 32922477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status.
    Bashash D; Sayyadi M; Safaroghli-Azar A; Sheikh-Zeineddini N; Riyahi N; Momeny M
    Int J Biochem Cell Biol; 2019 Mar; 108():7-16. PubMed ID: 30639430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis.
    Sayyadi M; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Abolghasemi H; Anoushirvani AA; Bashash D
    Arch Med Res; 2020 Oct; 51(7):636-644. PubMed ID: 32553459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Effects of PI3K and c-Myc Co-targeting in Acute Leukemia: Shedding New Light on Resistance to Selective PI3K-δ Inhibitor CAL-101.
    Riyahi N; Safaroghli-Azar A; Sheikh-Zeineddini N; Sayyadi M; Bashash D
    Cancer Invest; 2019; 37(7):311-324. PubMed ID: 31412710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Myc inhibition sensitizes pre-B ALL cells to the anti-tumor effect of vincristine by altering apoptosis and autophagy: Proposing a probable mechanism of action for 10058-F4.
    Sheikh-Zeineddini N; Safaroghli-Azar A; Salari S; Bashash D
    Eur J Pharmacol; 2020 Mar; 870():172821. PubMed ID: 31770526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of c-Myc using 10058-F4 exerts caspase-3-dependent apoptosis and intensifies the antileukemic effect of vincristine in pre-B acute lymphoblastic leukemia cells.
    Sheikh-Zeineddini N; Bashash D; Safaroghli-Azar A; Riyahi N; Shabestari RM; Janzamin E; Safa M
    J Cell Biochem; 2019 Aug; 120(8):14004-14016. PubMed ID: 30957273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of pan class-I PI3K induces differentially apoptotic pathways in acute leukemia cells: Shedding new light on NVP-BKM120 mechanism of action.
    Bashash D; Safaroghli-Azar A; Delshad M; Bayati S; Nooshinfar E; Ghaffari SH
    Int J Biochem Cell Biol; 2016 Oct; 79():308-317. PubMed ID: 27599915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519.
    Pourbagheri-Sigaroodi A; Safaroghli-Azar A; Shanaki M; Yousefi AM; Anjam Najmedini A; Bashash D
    Iran J Pharm Res; 2020; 19(3):144-155. PubMed ID: 33680018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Effects of PI3K Inhibition on Arsenic Trioxide Cytotoxicity in Acute Promyelocytic Leukemia Cells: A New Portrait of Idelalisib as an Adjuvant Therapy.
    Dadashi M; Pourbagheri-Sigaroodi A; Anjam-Najmedini A; Bashash D
    Indian J Hematol Blood Transfus; 2023 Apr; 39(2):208-219. PubMed ID: 37006983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line.
    Pourbagheri-Sigaroodi A; Bashash D; Safaroghli-Azar A; Farshi-Paraasghari M; Momeny M; Mansoor FN; Ghaffari SH
    Eur J Pharmacol; 2019 Mar; 846():49-62. PubMed ID: 30658112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance.
    Safaroghli-Azar A; Bashash D; Kazemi A; Pourbagheri-Sigaroodi A; Momeny M
    Eur J Pharmacol; 2019 Jan; 842():89-98. PubMed ID: 30401630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant.
    Bashash D; Safaroghli-Azar A; Bayati S; Razani E; Pourbagheri-Sigaroodi A; Gharehbaghian A; Momeny M; Sanjadi M; Rezaie-Tavirani M; Ghaffari SH
    Int J Biochem Cell Biol; 2018 Oct; 103():105-114. PubMed ID: 30145367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pan PI3K inhibitor-induced apoptosis in APL cells correlates with suppression of telomerase: An emerging mechanism of action of BKM120.
    Bashash D; Delshad M; Safaroghli-Azar A; Safa M; Momeny M; Ghaffari SH
    Int J Biochem Cell Biol; 2017 Oct; 91(Pt A):1-8. PubMed ID: 28834761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation.
    Klefstrom J; Arighi E; Littlewood T; Jäättelä M; Saksela E; Evan GI; Alitalo K
    EMBO J; 1997 Dec; 16(24):7382-92. PubMed ID: 9405367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK Blockade Using AT7519 Suppresses Acute Myeloid Leukemia Cell Survival through the Inhibition of Autophagy and Intensifies the Anti-leukemic Effect of Arsenic Trioxide.
    Zabihi M; Safaroghli-Azar A; Gharehbaghian A; Allahbakhshian Farsani M; Bashash D
    Iran J Pharm Res; 2019; 18(Suppl1):119-131. PubMed ID: 32802093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
    Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
    Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells.
    Mu Q; Ma Q; Lu S; Zhang T; Yu M; Huang X; Chen J; Jin J
    Oncol Lett; 2014 Sep; 8(3):1355-1359. PubMed ID: 25120723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRIMA-1 induces caspase-mediated apoptosis in acute promyelocytic leukemia NB4 cells by inhibition of nuclear factor-κB and downregulation of Bcl-2, XIAP, and c-Myc.
    Farhadi E; Safa M; Sharifi AM; Bashash D
    Anticancer Drugs; 2017 Jan; 28(1):51-58. PubMed ID: 27548348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-κB survival pathway in A375-S2 cells.
    He H; Zang LH; Feng YS; Chen LX; Kang N; Tashiro S; Onodera S; Qiu F; Ikejima T
    J Ethnopharmacol; 2013 Jul; 148(2):544-55. PubMed ID: 23684722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120.
    Bashash D; Delshad M; Riyahi N; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Momeny M
    Eur J Pharmacol; 2018 Dec; 841():10-18. PubMed ID: 30316766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.